Created in partnership with Parkinson's UK, the Critical Path for Parkinson's Consortium (CPP) was launched in 2015. It is a global collaboration that facilitates collaboration among scientists from the bio-pharmaceutical industry, academic institutions, government agencies, and patient-advocacy associations. It fosters consensus and data-driven research to increase efficiency, safety, and speed in developing new therapies.
Parkinson's research group receive data sharing award
27 January 2020
The Oxford Parkinson's Disease Centre received the award for their contribution to the Critical Path for Parkinson’s initiative